Alibaba Health Information Technology Limited ALBHF

Company Overview

Alibaba Health Information Technology Limited is a digital healthcare company operating primarily in the healthcare, pharmaceutical retail, and health technology industries. It focuses on integrating internet technology, data analytics, and supply chain capabilities to deliver healthcare products and services, with its core activities centered on pharmaceutical sales, medical and health services, and digital healthcare solutions. The company is listed on the Hong Kong Stock Exchange and trades in the U.S. over-the-counter market under the ticker ALBBY.

The company’s primary revenue drivers include direct pharmaceutical sales, an online pharmaceutical marketplace, and a growing suite of healthcare and wellness services. Its key customer segments are individual consumers seeking prescription and over-the-counter medications, healthcare products, and digital health services, as well as pharmaceutical manufacturers and distributors. Alibaba Health’s strategic advantage lies in its integration with the broader Alibaba ecosystem, including e-commerce infrastructure, logistics, cloud computing, and data capabilities. The company was established in 2014 and evolved through acquisitions and asset injections from Alibaba Group Holding Limited, positioning it as a core digital health platform within Alibaba’s broader consumer services strategy.